Found 6 matching trials
Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma PHASE2 Background:
The mainstay of therapy for newly diagnosed multiple myeloma p...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation PHASE3 Both patients and marrow donors are treated on Regimen A; patients then pro...
Show More Location
National Cancer Institute (NCI)
Learn More & Join Trial
Id-KLH Vaccine + T Cells in Subjects With Myeloma Undergoing Transplant PHASE2 This study will enroll myeloma subjects undergoing autotransplantation. The...
Show More Location
Abramson Cancer Center of the University of Pennsylvania
Learn More & Join Trial
Dendritic Cells(DC)-Based Id Vaccination in Stage-I Myeloma PHASE1 Patients with stage-I multiple myeloma are treated with a vaccine made from...
Show More Location
University Hospital Dresden
Learn More & Join Trial
Vaccine Therapy in Treating Patients With Multiple Myeloma Who Have Undergone Stem Cell Transplantation PHASE1 The purpose of this trial is to test the safety and immune response to four...
Show More Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Learn More & Join Trial
Vaccine Therapy in Treating Patients With Multiple Myeloma PHASE2 RATIONALE: Vaccines made from a person's tumor cells may make the body buil...
Show More Location
Arkansas Cancer Research Center
Learn More & Join Trial